RA Capital Management, LLC, 10% Owner at ACHILLION PHARMACEUTICALS INC (ACHN), bought 2,448,710 shares at $2.50 ($6.3M) on 2013-10-11, disclosed to the SEC on 2013-10-15.
Open-market purchase of $6.3M ACHN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.50 | 750,000 | $1.9M | 29.8% |
| 2 | $2.52 | 99,900 | $252K | 4.0% |
| 3 | $2.55 | 147,500 | $376K | 6.0% |
| 4 | $2.55 | 250,000 | $638K | 10.1% |
| 5 | $2.56 | 92,002 | $236K | 3.7% |
| 6 | $2.62 | 1,109,308 |
| $2.9M |
| 46.3% |
| Total | $2.57 avg | 2,448,710 | $6.3M | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |